Carlo Passarotti

This inventor holds 29 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Farmitalia Carlo Erba, Other. Active years: 1980-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlo Passarotti. Retrieved from https://idiyas.com/inventor/carlo-passarotti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 144(Granted Patents)

Location History:

Callarate, IT (1981)
Gallarate (Varese), IT (1985)
Gallarate, IT (1980 - 1987)

Company Filing History:

28 out of 208

Farmitalia Carlo Erba

patents

1 out of 834,513

Other

patents

Years Active: 1980-1987

Loading Chart...

Areas of Expertise:

Benzopyrone Derivatives

Thiazolo-Pyrimidines

Prostaglandins

Amino Derivatives

Pharmaceutical Composition

Carboxamido-Derivatives

Ethenyl Derivatives

Bicyclic Prostaglandins

PGI Compounds

Saturated PGI Compounds

Thiadiazolo-Pyrimidines

Pyrrolo-Quinazolines

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4665084 - Condensed benzopyrone derivatives (1987-05-12),

2. 4609660 - Substituted carboxy-thiazolo[3,2-a]pyrimidine derivatives (1986-09-02),

3. 4598090 - Condensed benzopyrone derivatives (1986-07-01),

4. 4579847 - Amino derivatives of benzylidene-pyrrolo[2,1-b]quinazolines useful for (1986-04-01),

5. 4558046 - Substituted carboxy-thiazolo [3,2-a] pyrimidine derivatives and process (1985-12-10),

6. 4551476 - 13,14-Didehydro-prostaglandins and process for their preparation (1985-11-05),

7. 4551457 - Substituted thiazolo[3,2-a]pyrimidines and process for their preparation (1985-11-05),

8. 4537962 - Substituted 1,3,4-thiadiazolo[3,2-A]pyrimidines and compositions (1985-08-27),

9. 4522944 - Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, (1985-06-11),

10. 4521419 - Condensed cycloaliphatic derivatives of substituted (1985-06-04),

11. 4490376 - Substituted ethenyl derivatives of 1H-pyrazolo-[1,5-a]pyrimidine having (1984-12-25),

12. 4482555 - Substituted 1H-pyrazolo (1,5-a) pyrimidines and process for their (1984-11-13),

13. 4444773 - Substituted thiazolo[3,2-a]pyrimidines and process for their preparation (1984-04-24),

14. 4428952 - Substituted pyrrolo[2,1-b]quinazolines and pyrido[2,1-b]quinazolines (1984-01-31),

15. 4328240 - Certain PGI.sub.1 compounds and their pharmaceutical composition and (1982-05-04),

Title: The Innovative Contributions of Carlo Passarotti

Introduction

Carlo Passarotti is a notable inventor based in Gallarate, Italy, recognized for his substantial contributions to the field of pharmaceuticals. With an impressive portfolio of 29 patents, he has demonstrated a strong commitment to developing innovative solutions for various health-related challenges. His work has particularly focused on compounds that hold therapeutic potential, especially in treating allergic conditions.

Latest Patents

Among his latest innovations are the following patents:

1. **Condensed Benzopyrone Derivatives** - This patent pertains to new condensed benzopyrone derivatives that feature a 5-tetrazolyl substituent. The invention also includes pharmaceutical compositions containing these derivatives, which are promising for the treatment of allergic conditions.

2. **Substituted Carboxy-Thiazolo[3,2-a]Pyrimidine Derivatives** - This patent involves carboxy-thiazolo[3,2-a]pyrimidine derivatives and their pharmaceutical compositions. These compounds are identified to possess significant anti-allergic activity, enhancing therapeutic options for patients.

Career Highlights

Carlo Passarotti has had a distinguished career, with significant experience in the pharmaceutical industry. One of the prominent companies he has worked with is Farmitalia Carlo Erba S.p.a., which reflects his deep engagement in the development of innovative pharmaceutical products.

Collaborations

Throughout his career, Passarotti has collaborated with esteemed colleagues such as Carmelo Gandolfi and Angelo Fumagalli. These collaborations have likely contributed to the richness and depth of his research, fostering advancements in pharmaceutical solutions.

Conclusion

Carlo Passarotti's vast array of patents and contributions to pharmaceutical innovation is a testament to his expertise as an inventor. His dedication to developing compounds with therapeutic potential showcases the role of innovation in addressing health challenges. With a focus on allergic conditions, his work serves as an inspiring example of how inventors can impact the medical field positively.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]